Women who are pregnant or nursing, or who have certain medical conditions, should only consider it after clearance from a qualified provider
In a notable advance for patient convenience, the FDA approved oral semaglutide 25 mg (oral Wegovy) following the positive OASIS 4 trial, which showed 16.6% mean weight loss at 64 weeks
Say goodbye to dark spots, uneven skin tone, and acne, and hello to a radiant, youthful complexion
However, recent studies have uncovered its potential as a weight loss aid, offering hope to millions
Incidence and Management of Semaglutide-Induced Rash: A Comprehensive Review. Pharmacotherapy, 28(3), 189-197
This is why expiration awareness and proper cold-chain management are foundational to any precision GLP-1 regimen